BACKGROUND & AIMS: Intrahepatic accumulation of CD8+ T cells following antigen-specific activation has been demonstrated in a number of transgenic models and also in extrahepatic viral infections. In some transgenic models, intrahepatic accumulation of cytotoxic T lymphocytes is associated with hepatitis. This observation suggests that hepatocellular damage may occur in some forms of immune-mediated hepatitis on the basis of a "bystander injury," whereby cytotoxic T lymphocytes accumulating in the liver mediate injury to hepatocytes in a nonspecific manner. Mouse transgenic models were therefore developed to investigate whether bystander damage to non-antigen-bearing hepatocytes occurs in vivo. METHODS: T cell receptor transgenic T cells were adoptively transferred into transgenic mice ubiquitously expressing the specific antigen, or into bone marrow radiation chimeras in which hepatocytes did not express the antigen. RESULTS: Selective accumulation of transgenic CD8+ T cells in the liver of intact recipients could be detected within 2 hours of transfer, despite ubiquitous antigenic expression. T cells retained in the liver were activated and induced hepatitis. Similar results were obtained using bone marrow chimeras, suggesting that antigen expression by hepatocytes was not required either for intrahepatic accumulation or for subsequent hepatitis. This "bystander hepatitis" was dependent on tumor necrosis factor alpha and interferon gamma. CONCLUSIONS: Intrahepatic accumulation of activated CD8+ T cells and subsequent hepatitis can result from primary activation of CD8+ T cells by liver resident bone marrow-derived cells, inducing bystander damage to non-antigen-bearing hepatocytes. This mechanism may play a role in some forms of biologically significant hepatitis, including autoimmune hepatitis and hepatitis associated with extrahepatic diseases.
BACKGROUND & AIMS:Intrahepatic accumulation of CD8+ T cells following antigen-specific activation has been demonstrated in a number of transgenic models and also in extrahepatic viral infections. In some transgenic models, intrahepatic accumulation of cytotoxic T lymphocytes is associated with hepatitis. This observation suggests that hepatocellular damage may occur in some forms of immune-mediated hepatitis on the basis of a "bystander injury," whereby cytotoxic T lymphocytes accumulating in the liver mediate injury to hepatocytes in a nonspecific manner. Mousetransgenic models were therefore developed to investigate whether bystander damage to non-antigen-bearing hepatocytes occurs in vivo. METHODS: T cell receptor transgenic T cells were adoptively transferred into transgenic mice ubiquitously expressing the specific antigen, or into bone marrow radiation chimeras in which hepatocytes did not express the antigen. RESULTS: Selective accumulation of transgenic CD8+ T cells in the liver of intact recipients could be detected within 2 hours of transfer, despite ubiquitous antigenic expression. T cells retained in the liver were activated and induced hepatitis. Similar results were obtained using bone marrow chimeras, suggesting that antigen expression by hepatocytes was not required either for intrahepatic accumulation or for subsequent hepatitis. This "bystander hepatitis" was dependent on tumor necrosis factor alpha and interferon gamma. CONCLUSIONS:Intrahepatic accumulation of activated CD8+ T cells and subsequent hepatitis can result from primary activation of CD8+ T cells by liver resident bone marrow-derived cells, inducing bystander damage to non-antigen-bearing hepatocytes. This mechanism may play a role in some forms of biologically significant hepatitis, including autoimmune hepatitis and hepatitis associated with extrahepatic diseases.
Authors: Volker Benseler; Alessandra Warren; Michelle Vo; Lauren E Holz; Szun S Tay; David G Le Couteur; Eamon Breen; Anthony C Allison; Nico van Rooijen; Claire McGuffog; Hans J Schlitt; David G Bowen; Geoffrey W McCaughan; Patrick Bertolino Journal: Proc Natl Acad Sci U S A Date: 2011-09-20 Impact factor: 11.205
Authors: Szun Szun Tay; Yik Chun Wong; David M McDonald; Nicole A W Wood; Ben Roediger; Frederic Sierro; Claire Mcguffog; Ian E Alexander; G Alex Bishop; Jennifer R Gamble; Wolfgang Weninger; Geoffrey W McCaughan; Patrick Bertolino; David G Bowen Journal: Proc Natl Acad Sci U S A Date: 2014-06-10 Impact factor: 11.205
Authors: Noelle K Polakos; Judith C Cornejo; Debbie A Murray; Kate O Wright; John J Treanor; I Nicholas Crispe; David J Topham; Robert H Pierce Journal: Am J Pathol Date: 2006-04 Impact factor: 4.307
Authors: David G Bowen; Monica Zen; Lauren Holz; Thomas Davis; Geoffrey W McCaughan; Patrick Bertolino Journal: J Clin Invest Date: 2004-09 Impact factor: 14.808
Authors: K E Lunsford; K Jayanshankar; A M Eiring; P H Horne; M A Koester; D Gao; G L Bumgardner Journal: Am J Transplant Date: 2008-06 Impact factor: 8.086